These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24473660)

  • 1. [Bioterrorism and pathogenic microorganisms].
    Schatzmayr HG; Barth OM
    Hist Cienc Saude Manguinhos; 2013 Oct; 20(4):1735-49. PubMed ID: 24473660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Being prepared: bioterrorism and mass prophylaxis: part II.
    Weant KA; Bailey AM; Fleishaker EL; Justice SB
    Adv Emerg Nurs J; 2014; 36(4):307-17; quiz 318-9. PubMed ID: 25356890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Being prepared: bioterrorism and mass prophylaxis: part I.
    Weant KA; Bailey AM; Fleishaker EL; Justice SB
    Adv Emerg Nurs J; 2014; 36(3):226-38; quiz 239-40. PubMed ID: 25076398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological agents: weapons of warfare and bioterrorism.
    Broussard LA
    Mol Diagn; 2001 Dec; 6(4):323-33. PubMed ID: 11774197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Germs and toxins in bioterrorism].
    Inoue N
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():81-91. PubMed ID: 12722194
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular diagnostic techniques for use in response to bioterrorism.
    Firmani MA; Broussard LA
    Expert Rev Mol Diagn; 2003 Sep; 3(5):605-16. PubMed ID: 14510181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical aspects of bio-terrorism.
    Balali-Mood M; Moshiri M; Etemad L
    Toxicon; 2013 Jul; 69():131-42. PubMed ID: 23339855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microbiology laboratory's role in response to bioterrorism.
    Robinson-Dunn B
    Arch Pathol Lab Med; 2002 Mar; 126(3):291-4. PubMed ID: 11860302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioterrorism: class A agents and their potential presentations in immunocompromised patients.
    Richard JL; Grimes DE
    Clin J Oncol Nurs; 2008 Apr; 12(2):295-302. PubMed ID: 18390465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioterrorism. Clinical recognition and primary management.
    Branda JA; Ruoff K
    Am J Clin Pathol; 2002 Jun; 117 Suppl():S116-23. PubMed ID: 14569808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Germs employed as biological weapons].
    Meyer CG; May J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Sep; 37(9):538-46. PubMed ID: 12215940
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bioterrorism].
    Sata T
    Nihon Hoigaku Zasshi; 2005 Oct; 59(2):119-25. PubMed ID: 16296383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of eleven commercially available rapid tests for detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis.
    Zasada AA; Formińska K; Zacharczuk K; Jacob D; Grunow R
    Lett Appl Microbiol; 2015 May; 60(5):409-13. PubMed ID: 25598285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern possibilities of bioterrorism diagnosis].
    Grzesiowski P; Szafraniec S; Chmylak B; Tylewska-Wierzbanowska S; Hryniewicz W
    Pol Merkur Lekarski; 2003 Feb; 14(80):142-5. PubMed ID: 12728676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.
    Guarner J; Zaki SR
    J Histochem Cytochem; 2006 Jan; 54(1):3-11. PubMed ID: 16148309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathobiology and management of laboratory rodents administered CDC category A agents.
    He Y; Rush HG; Liepman RS; Xiang Z; Colby LA
    Comp Med; 2007 Feb; 57(1):18-32. PubMed ID: 17348288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus anthracis, Francisella tularensis and Yersinia pestis. The most important bacterial warfare agents - review.
    Pohanka M; Skládal P
    Folia Microbiol (Praha); 2009; 54(4):263-72. PubMed ID: 19826916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New diagnostic methods for bacterial infections after the introduction of increased bioterrorism preparedness].
    Christensen JJ; Andresen K; Kemp M
    Ugeskr Laeger; 2005 Sep; 167(36):3416-7. PubMed ID: 16159496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid field detection assays for Bacillus anthracis, Brucella spp., Francisella tularensis and Yersinia pestis.
    Matero P; Hemmilä H; Tomaso H; Piiparinen H; Rantakokko-Jalava K; Nuotio L; Nikkari S
    Clin Microbiol Infect; 2011 Jan; 17(1):34-43. PubMed ID: 20132255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents.
    Greenfield RA; Bronze MS
    Drug Discov Today; 2003 Oct; 8(19):881-8. PubMed ID: 14554016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.